Advertisement

Aug 12, 2010 7:00AM
Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration for PSI-7977 for the treatment of chronic hepatitis C virus infection. ...
Aug 12, 2010 7:00AM
Pharmasset, Inc. has received fast track designation from the U.S. Food and Drug Administration for PSI-7977 for the treatment of chronic hepatitis C virus infection. ...
Aug 09, 2010 4:15PM
Pharmasset, Inc. , a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported...
Aug 09, 2010 4:15PM
Pharmasset, Inc. , a clinical stage pharmaceutical company committed to discovering, developing, and commercializing novel drugs to treat viral infections, today reported...
Jul 30, 2010 4:30PM
Pharmasset, Inc. announces that management will present at the Wedbush Life Sciences Best Ideas: Management Access Conference being held on August 3, 2010 at the Le Park...
Jul 28, 2010 6:45AM
Pharmasset, Inc. announced today that safety and pharmacokinetic data from the PSI-352938 ("PSI-938") single ascending dose study support progression to a mult...
advertisement
advertisement